Research Events

27 Sep 2019

Organizers: IRB Barcelona
Date: Friday 27 September, 12.00h
Place: Auditorium, Parc Cientific de Barcelona

Host: Nuria Lopez-Bigas, PhD - IRB Barcelona

Abstract:

27 Sep 2019 - 28 Sep 2019

IRB Barcelona will be participating in the following activities in this years’ event:

 

Friday, 27 September 2019

Gate2Brain, a door to cure the brain (Meritxell Teixidó)
Short talk, 17:00-18:00, Centre Cívic Urgell

New antitumor drugs based on Alpaca antibodies (Salvador Guardiola)
Short talk, 17:30-18:00, Vil·la Urània

1 Oct 2019

Organizers: IRB Barcelona
Date: Tuesday 1 October, 12.00h
Place: Felix Serratosa Hall, Parc Cientific de Barcelona

Host: Fran Supek, PhD - IRB Barcelona

Abstract

4 Oct 2019

Organizers: IRB Barcelona
Date: Friday 4th October, 12.00h
Place: Auditori PCB, Parc Cientific de Barcelona

Plenary Seminar

11 Oct 2019

Organizers: IRB Barcelona
Date: Friday 11 October, 12.00h
Place: Felix Serratosa Hall, Parc Cientific de Barcelona

Host: Lluís Ribas de Pouplana, PhD - IRB Barcelona

Abstract:

13 Nov 2019 - 15 Nov 2019

Date: 13-15 November 2019
Place: Van der Valk hotel, Nijmegen (Netherlands)

 

Early bird registration period:  April 1 – June 30, 2019

Notification of travel grants awardees:  July 31, 2019

Late registration period:  July 1 – September 16, 2019

Notification of abstract selection:  October 2019

 

Register here:

http://enablenetwork.eu/registration/

 

 

18 Nov 2019 - 20 Nov 2019

Stimulation of the immune system by blocking immunosuppressive checkpoints has shown spectacular impact in cancer therapy. There is increasing evidence that immunotherapy might elicit similar outcomes in non-oncological settings. This is the case, for example, of neurodegenerative disorders where blockade of immune checkpoints has beneficial effects.  More generally, aging is associated with a progressive unbalance in the composition and activity of the different components of the immune system.

15 Jun 2020 - 17 Jun 2020

Cancer is the second leading cause of death worldwide, and a problem that escalates in an aging population. Although significant progress has been made in understanding the genetic and epigenetic determinants of cancer, little attention has been paid to post-transcriptional regulation of gene expression. The process of mRNA translation shapes the proteome and plays an essential role in the reprogramming of cancerous cells, holding the promise of novel anti-cancerous therapies.